Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 25 February 2005:
Vol. 307. no. 5713, p. 1183
DOI: 10.1126/science.307.5713.1183b
Prev | Table of Contents | Next

ScienceScope

The Bill and Melinda Gates Foundation once again has put its money where its mouth is, with a $360 million investment in AIDS vaccine research.

The money, so far the largest single contribution to the field, supports the goals of the HIV/AIDS Global Vaccine Enterprise, an international alliance that the Gates Foundation helped organize. The new funds will go to research centers or consortia that are trying to improve tests to assess the immune responses triggered by vaccines or design vaccines that stimulate either antibodies or cell-mediated immunity. Letters of inquiry are due by 1 April. The size and number of awards will depend upon the quality and scope of the proposals.




To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)